Canaccord Genuity Maintains a 'Buy' on AVEO Pharmaceuticals (AVEO); Tivo Still Positioned Well in the Face of Decent Axitinib Data
Go back to Canaccord Genuity Maintains a 'Buy' on AVEO Pharmaceuticals (AVEO); Tivo Still Positioned Well in the Face of Decent Axitinib Data| AVEO PHARMA (NASDAQ: AVEO) | Delayed: 15.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.00 | 52 Week High | $1.42 | |||
| Open | $29.63 | 52 Week Low | $0.56 | |||
| Day High | $15.00 | P/E | N/A | |||
| Day Low | $15.00 | EPS | $-2.28 | |||
| Volume | 4,180,688 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 27.79 -0.45 (1.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.24 | 52 Week High | $37.39 | |||
| Open | $28.00 | 52 Week Low | $28.25 | |||
| Day High | $28.16 | P/E | 16.84 | |||
| Day Low | $27.65 | EPS | $1.65 | |||
| Volume | 29,267,689 | |||||

